Skip to Content

Enjuvia Approval History

FDA Approved: Yes (Discontinued) (First approved May 10, 2004)
Brand name: Enjuvia
Generic name: synthetic conjugated estrogens, B
Dosage form: Tablets
Company: Duramed Pharmaceuticals
Treatment for: Postmenopausal Symptoms, Atrophic Vaginitis

Marketing Status: Discontinued

Enjuvia (synthetic conjugated estrogens, B) is a synthetic conjugated estrogen product indicated for the treatment of menopausal vasomotor symptoms and for the treatment of vaginal dryness and atrophy.

Development History and FDA Approval Process for Enjuvia

DateArticle
Apr 30, 2007Approval Duramed's Enjuvia (Synthetic Conjugated Estrogens, B) TabletsReceives Two New FDA Approvals
May 10, 2004Approval Enjuvia Duramed Pharmaceuticals - Treatment for Menopausal Vasomotor Symptoms

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide